3 Things I Discovered at My 50th College Reunion
My wife and I recently returned from a long weekend in upstate New York, where we attended my college reunion.
Articles by Ed Tobias
MS News That Caught My Eye Last Week: Deep Brain Stimulation, Evobrutinib, Hydroxychloroquine, Ocrevus and PML
Deep Brain Stimulation May Help With MS-associated Tremors Deep brain stimulation (DBS) has been used to treat people with…
Amazon Care to Expand Company’s Reach Into Healthcare Services
Would you sign up for healthcare from the place where you buy books, bluejeans, and bagels? Amazon thinks you might,…
MS News That Caught My Eye Last Week: Ublituximab, ATA188, COVID-19, Cognitive Rehab
Ublituximab, Potential Relapsing MS Therapy, Up for FDA Approval Like Ocrevus (ocrelizumab) and Kesimpta (ofatumumab), ublituximab targets the CD20…
Humana’s Lawsuit Against Biogen Decries Ongoing ‘Seed and Sweep’ Schemes
People living with multiple sclerosis know that the medications used to treat it are expensive. According to the National Multiple…
MS News That Caught My Eye Last Week: Bladder Treatment, Anti-CD20 DMTs, Cancer and MS, Seasons and MS
Oral Fesoterodine Fumarate Can Ease Bladder Problems in MS This is a biggie for me since bladder problems have…
Are Generic and Brand-name Pills Created Equal?
I take a bunch of pills every day. Most of them are generics. I’ve used baclofen to treat my leg…
MS News That Caught My Eye Last Week: COVID-19 Vaccines, Bladder and Bowel Problems, Rim Lesions
Patients on Anti-CD20 Therapies Urged to Get COVID-19 Vaccine Some people being treated with disease-modifying therapies (DMTs) that reduce…
Assessing My Pain, From Zero to 10
Lately, I’ve been thinking about pain — specifically, how to count my pain. When I was lying on a treatment…
MS News That Caught My Eye Last Week: COVID-19 Vaccine and Relapse, Protective Parasite, Vibration Training, Infections
Risk of MS Relapse Not Increased by COVID-19 Vaccine, Study Finds This new information about one of the COVID-19…
MS Paralympian Aims for a Bull’s-eye
Lia Coryell says she wanted to die. According to The New York Times, after fighting COVID-19 last winter, Coryell…
With MS, a New Pair of Shoes Makes a Big Difference
I wish I could walk a mile in my shoes, but even with a new pair, that’s not going to…
MS News That Caught My Eye Last Week: Ocrevus, Myelin Repair, Early MS Problems, Black MS Experience Summit
Ocrevus Reduces MS Relapse Risk, But Linked to More Hospitalizations As you can see from the first two paragraphs…
I’m Trying a Different Medication, Myrbetriq, for My Urinary Issues
I’ve had pee problems for as long as I’ve had multiple sclerosis. Many folks with MS have issues, including…
MS News That Caught My Eye Last Week: Ocrevus, Probiotics, Floodlight App, Sativex in UK
Trial Will Test Ocrevus on Arm, Hand Function in PPMS A lot of the focus in MS treatment and…
Do People With MS Need a 3rd Vaccine Shot?
Now that a third COVID-19 vaccine shot has been approved in the U.S. for immunocompromised people, and vaccine boosters…
MS News That Caught My Eye Last Week: Mavenclad, Sativex, Mistreatment, Patient Survey
Trial Will Test Mavenclad for Advanced Progressive MS I often think that researchers have forgotten about people whose MS…
Can Special Diets or Vitamin Supplements Ease My MS Symptoms?
Can I survive without dessert? Can I live without ice cream, chocolate, and fruit pies, or with only a small…
MS News That Caught My Eye Last Week: COVID-19, High-dose Biotin, MS Diets, Tysabri
Risk of Severe COVID-19 Not Raised by Immunosuppressive DMTs Here’s the latest on whether disease-modifying therapies (DMTs) raise the…
Getting Something Off My Chest
May I vent, please? In the five years that I’ve been writing this column, I don’t think I’ve ever used…
MS News That Caught My Eye Last Week: Stem Cells, Home Infusions, Hippocampus
FDA Greenlights Stem Cells Trial Aiming to Improve Quality of Life I’m pleased every time I see stem cell…
Could BTK Inhibitors Be the Next Big MS Treatment?
Is orelabrutinib one of the next big MS therapies? Biogen is betting at least $125 million that it is.
MS News That Caught My Eye Last Week: Mavenclad, Genetic Risk, Fatigue Impact, Multivitamins
Skin Reactions ‘Frequent’ With Mavenclad, Real-world Study Finds I regularly see people posting on social media about having a…
It’s Not a Crime to Ask for Help When You Need It
“Do you need help?” The question came from a 30-something woman after I’d finished loading some cartons into the back…
MS News That Caught My Eye Last Week: Orelabrutinib, MS Stress, Selma Blair
Biogen Strikes Deal for Orelabrutinib, Now in Phase 2 Trial BTK inhibitors, such as orelabrutinib, are designed to selectively…
Using Cannabis to Treat Your MS? A Word of Caution
People with MS who are using cannabis take heed: A research letter published in May in JAMA Network Open…
MS News That Caught My Eye Last Week: Sativex, IMU-838, Ibudilast, Supercomputer
Sativex Eased MS Spasticity as an Add-on Therapy A reader in Belgium told me he has used Sativex for…
Don’t Let MS Stop You From Grandparenting
My grandson, John, turned 5 in May, and my granddaughter, Hayden, turned 7 in June. I love being their Poppy,…
Sativex Study Reports Positive Results in People With MS
Could a cannabis spray be just what the doctor ordered to treat our MS symptoms? I’m talking about Sativex…
MS News That Caught My Eye Last Week: MS Diet, Early Symptoms, Kesimpta, Spinal Fluid Test
MIND Diet May Protect Brain Tissue in MS The Mediterranean Diet is one of several diets that proponents believe…